Walter & Keenan Wealth Management’s Gilead Sciences GILD Stock Holding History

Walter & Keenan Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,780	Closed	-$214K	–	144
2020 Q2	$214K	Buy	+2,780	New	+$213K	0.09%	134
2019 Q1	–	Sell	-3,270	Closed	-$205K	–	159
2018 Q4	$205K	Sell	3,270 -1,000	-23%	-$69.9K	0.09%	146
2018 Q3	$330	Sell	4,270 -1,000	-19%	-$75.5K	0.1%	119
2018 Q2	$373K	Sell	5,270 -830	-14%	-$58.6K	0.16%	112
2018 Q1	$460K	Sell	6,100 -70	-1%	-$5.57K	0.2%	100
2017 Q4	$442K	Sell	6,170 -630	-9%	-$47.8K	0.19%	103
2017 Q3	$551K	Buy	6,800 +3,000	+79%	+$229K	0.25%	84
2017 Q2	$269K	Buy	+3,800	New	+$253K	0.14%	124
2016 Q3	–	Sell	-2,400	Closed	-$200K	–	143
2016 Q2	$200K	Sell	2,400 -600	-20%	-$53.2K	0.11%	132
2016 Q1	$276K	Sell	3,000 -1,000	-25%	-$90.2K	0.16%	107
2015 Q4	$405K	Hold	4,000	–	–	0.24%	90
2015 Q3	$393K	Buy	4,000 +600	+18%	+$66.6K	0.24%	89
2015 Q2	$398K	Hold	3,400	–	–	0.23%	92
2015 Q1	$334K	Buy	3,400 +1,000	+42%	+$102K	0.19%	110
2014 Q4	$226K	Hold	2,400	–	–	0.13%	127
2014 Q3	$255K	Buy	+2,400	New	+$235K	0.15%	123

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Walter & Keenan Wealth Management's GILD Position: Q3 2020 in Review

Walter & Keenan Wealth Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,780 shares — an estimated $214K sold.

Walter & Keenan Wealth Management first reported a position in GILD in Q3 2014 and held it in 16 quarters. The position peaked at $551K in Q3 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Walter & Keenan Wealth Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Walter & Keenan Wealth Management sold 2,780 Gilead Sciences shares in Q3 2020, an estimated $214K.
Walter & Keenan Wealth Management first reported a position in Gilead Sciences in Q3 2014 and held it in 16 quarters.
Walter & Keenan Wealth Management's Gilead Sciences position peaked at $551K in Q3 2017.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Walter & Keenan Wealth Management's 13F filing for Q3 2020, filed 27 Oct 2020.